356 related articles for article (PubMed ID: 28604268)
21. rgpA DNA vaccine induces antibody response and prevents alveolar bone loss in experimental peri-implantitis.
Fan X; Wang Z; Ji P; Bian Y; Lan J
J Periodontol; 2013 Jun; 84(6):850-6. PubMed ID: 22917113
[TBL] [Abstract][Full Text] [Related]
22. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
[TBL] [Abstract][Full Text] [Related]
23. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
24. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.
Kuboniwa M; Amano A; Shizukuishi S; Nakagawa I; Hamada S
Infect Immun; 2001 May; 69(5):2972-9. PubMed ID: 11292714
[TBL] [Abstract][Full Text] [Related]
25. Expression of Porphyromonas gingivalis gingipain antigen Hgp44 domain on surface of Lactococcus lactis.
Yamamoto I; Ishihara K; Muramatsu K; Wada Y; Kiwaki M; Kushiro A; Okuda K
Bull Tokyo Dent Coll; 2013; 54(4):233-41. PubMed ID: 24521549
[TBL] [Abstract][Full Text] [Related]
26. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
Katz J; Black KP; Michalek SM
Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
[TBL] [Abstract][Full Text] [Related]
27. Arg-gingipain A DNA vaccine prevents alveolar bone loss in mice.
Miyachi K; Ishihara K; Kimizuka R; Okuda K
J Dent Res; 2007 May; 86(5):446-50. PubMed ID: 17452566
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
Yang QB; Martin M; Michalek SM; Katz J
Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
[TBL] [Abstract][Full Text] [Related]
29. Vaccination and periodontitis: myth or reality.
Page RC
J Int Acad Periodontol; 2000 Apr; 2(2):31-43. PubMed ID: 12666959
[TBL] [Abstract][Full Text] [Related]
30. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
[TBL] [Abstract][Full Text] [Related]
31. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model--involvement of gingipains and responses to re-infection.
Yoneda M; Hirofuji T; Motooka N; Anan H; Hamachi T; Miura M; Ishihara Y; Maeda K
J Periodontal Res; 2003 Dec; 38(6):551-6. PubMed ID: 14632916
[TBL] [Abstract][Full Text] [Related]
32. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
Kohler JJ; Pathangey LB; Gillespie SR; Brown TA
Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of an HA2 domain-based periodontitis vaccine.
DeCarlo AA; Huang Y; Collyer CA; Langley DB; Katz J
Infect Immun; 2003 Jan; 71(1):562-6. PubMed ID: 12496212
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
[TBL] [Abstract][Full Text] [Related]
35. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
Wilensky A; Polak D; Houri-Haddad Y; Shapira L
J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
[TBL] [Abstract][Full Text] [Related]
36. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model.
Gonzalez D; Tzianabos AO; Genco CA; Gibson FC
Infect Immun; 2003 Apr; 71(4):2283-7. PubMed ID: 12654858
[TBL] [Abstract][Full Text] [Related]
37. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X; LaRosa KB; Kawai T; Taubman MA
Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection.
Frazer LT; O'Brien-Simpson NM; Slakeski N; Walsh KA; Veith PD; Chen CG; Barr IG; Reynolds EC
Vaccine; 2006 Oct; 24(42-43):6542-54. PubMed ID: 16839648
[TBL] [Abstract][Full Text] [Related]
39. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
40. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
